The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study.

Saved in:
Bibliographic Details
Title: The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study.
Authors: Schultebraucks K; Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA. Katharina.Schultebraucks@nyulangone.org.; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA. Katharina.Schultebraucks@nyulangone.org., Blekic W; Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA., Basaraba C; Area Mental Health Data Science, New York State Psychiatric Institute, New York, NY, USA., Corbeil T; Area Mental Health Data Science, New York State Psychiatric Institute, New York, NY, USA., Khan Z; Department of Biomedical Engineering, Columbia University, New York, NY, USA., Henry BF; Rehabilitation and Human Services, Educational Psychology, Counseling, and Special Education, College of Education Consortium on Substance Use and Addiction, Social Science Research Institute, Pennsylvania State University, State College, PA, USA., Krawczyk N; Center for Opioid Epidemiology and Policy, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA., Rivera BD; Center for Opioid Epidemiology and Policy, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA., Allen B; Center for Opioid Epidemiology and Policy, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA., Arout C; Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY, USA., Pincus HA; Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY, USA.; Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA.; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA., Martinez DM; Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY, USA.; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA., Levin FR; Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY, USA.; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Source: Molecular psychiatry [Mol Psychiatry] 2023 Jun; Vol. 28 (6), pp. 2462-2468. Date of Electronic Publication: 2023 Apr 17.
Publication Type: Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5578
DOI:10.1038/s41380-023-02049-4